Weekly digest: the latest news on topics important to Open Pharma

Featuring the importance of net neutrality freedoms for science, the Open Pharma workstream June report and a defence of post-publication peer review. What do threats to net neutrality mean for scholarly publishing? via PLOS Blogs In the wake of the widespread  protests in support of net neutrality that took place on Wednesday, this blog reflects … Continue reading Weekly digest: the latest news on topics important to Open Pharma

Update on Open Pharma workstreams: June 2017

Since the launch of Open Pharma in January 2017, groups of stakeholders have convened on a monthly basis to explore how to implement positive changes in scientific publishing across four key areas: open access; ORCID, CRediT and Convey; preprints and post-publication peer review; and layered publication platforms. The collated key insights and next steps from … Continue reading Update on Open Pharma workstreams: June 2017